Cécile Chartier
Io Therapeutics (United States)(US)
Publications by Year
Research Areas
CAR-T cell therapy research, Cancer-related gene regulation, Cancer Immunotherapy and Biomarkers, Immunotherapy and Immune Responses, Virus-based gene therapy research
Most-Cited Works
- → Efficient generation of recombinant adenovirus vectors by homologous recombination in Escherichia coli(1996)650 cited
- → Wnt pathway inhibition via the targeting of Frizzled receptors results in decreased growth and tumorigenicity of human tumors(2012)620 cited
- → Colorectal Cancer Stem Cells Are Enriched in Xenogeneic Tumors Following Chemotherapy(2008)582 cited
- → Lifileucel, a Tumor-Infiltrating Lymphocyte Therapy, in Metastatic Melanoma(2021)382 cited
- → Final results of the EORTC 18871/DKG 80-1 randomised phase III trial(2003)240 cited
- → Directed Evolution Generates a Novel Oncolytic Virus for the Treatment of Colon Cancer(2008)210 cited
- → VEGF modulates erythropoiesis through regulation of adult hepatic erythropoietin synthesis(2006)158 cited
- → WNT antagonists exhibit unique combinatorial antitumor activity with taxanes by potentiating mitotic cell death(2017)154 cited
- → Therapeutic Targeting of Tumor-Derived R-Spondin Attenuates β-Catenin Signaling and Tumorigenesis in Multiple Cancer Types(2016)113 cited
- Novel complementation cell lines derived from human lung carcinoma A549 cells support the growth of E1-deleted adenovirus vectors.(1996)